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Background: Self-assembling peptides that form nanostructured hydrogels are important biomaterials for tissue
engineering scaffolds. The P11-family of peptides includes, P11-4 (QQRFEWEFEQQ) and the complementary peptides
P11-13 (EQEFEWEFEQE) and P11-14 (QQOrnFOrnWOrnFOrnQQ). These form self-supporting hydrogels under
physiological conditions (pH 7.4, 140 mM NaCl) either alone (P11-4) or when mixed (P11-13 and P11-14). We report a
SUMO-peptide expression strategy suitable for allowing release of native sequence peptide by SUMO protease
cleavage.
Results: We have expressed SUMO-peptide fusion proteins from pET vectors by using autoinduction methods.
Immobilised metal affinity chromatography was used to purify the fusion protein, followed by SUMO protease
cleavage in water to release the peptides, which were recovered by reverse phase HPLC. The peptide samples were
analysed by electrospray mass spectrometry and self-assembly was followed by circular dichroism and transmission
electron microscopy.
Conclusions: The fusion proteins were produced in high yields and the β-structured peptides were efficiently
released by SUMO protease resulting in peptides with no additional amino acid residues and with recoveries of
46% to 99%. The peptides behaved essentially the same as chemically synthesised and previously characterised
recombinant peptides in self-assembly and biophysical assays.
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Rationally designed self-assembling peptides have recently
attracted widespread attention for the development of
novel biomaterials in applications such as tissue engineer-
ing scaffolds [1-5] and dental enamel remineralisation [6].
The P11-family of peptides comprises over 20 different pep-
tides designed by Aggeli and colleagues to self-assemble
into β-sheet structures under various physicochemical con-
ditions to form isotropic hydrogels at peptide concentra-
tions of 10–30 mg/mL [7-9]. These peptides have varying
overall charge, hydrophobicity, and polar amino acids
resulting in a difference in properties such as solvent affin-
ity, dissolution rate and rigidity of gels.* Correspondence: m.j.mcpherson@leeds.ac.uk
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reproduction in any medium, provided the orChemically synthesised peptide P11-4 (CH3CO-QQRFE
WEFEQQ-NH2) is a pH responsive self assembling peptide
which forms β-sheets and nematic gels at a concentration
of 12.6 mM in water on a pH trigger [7,8] or under physio-
logical conditions in cell culture medium (DMEM) at pH
7.4 [10]. Peptides P11-13 (CH3CO-EQEFEWEFEQE-NH2)
and P11-14 (CH3CO-QQOFOWOFOQQ-NH2) are com-
plementary self-assembling peptides that will not self-
assemble independently but when combined they assemble
with each other to form a hydrogel [11].
Recently there have been reports of recombinant pro-
duction of self-assembling peptides although there can
be issues of low production levels, cell toxicity and deg-
radation by proteases [12-14]. For short peptides <50
amino acids these issues are normally addressed by
expressing the peptide as part of a larger ‘fusion partner
protein’ to optimise intracellular stability and facilitate
affinity isolation during purification. However, therel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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fusion partner.
Previous work on recombinant production of the β-
structured P11 self-assembling peptides has focused upon
a ketosteroid isomerase fusion partner to produce peptides
P11-4 [10,12] and P11-2 [15]. These studies reported a
maximal yield of 4.6 g fusion protein/L culture for P11-4
[10] by autoinduction [16]. However, the fusion proteins
accumulate as insoluble inclusion bodies and peptides are
released by denaturation followed by chemical cleavage of
a methionine residue with cyanogen bromide [10,12] or a
cysteine residue with 1-cyano-4-dimethylaminopyridinium
[15]. The use of chemicals for cleavage can lead to pro-
blems of disposal on scale-up and results in a non-native
peptide sequence. Thioredoxin has also been used as a fu-
sion partner with enzymatic cleavage to release fused pep-
tides, in this case with tobacco etch virus protease [17].
However, this leaves either a Gly or Ser as the N-terminal
residue and so usually results in a non-native N-terminus.
In the present study, we have used SUMO (small ubiqui-
tin-related modifier) protein as a fusion partner for various
self-assembling P11-peptides to address the question, can
high yields of self assembling P11-family peptide with native
termini be produced from a soluble fusion protein system?
SUMO fusion technology has been widely used for difficult
to express peptides and proteins [18] and due to the nature
of cleavage by the SUMO protease, which recognises a
structural rather than sequence feature, allows the produc-
tion of proteins or peptides with any N-terminal residue
[19,20]. The approach uses the S. cerevisiae SUMO as a fu-
sion partner to allow soluble expression of fusion proteins
which can be easily purified using an affinity purification
tag. The tertiary structure of SUMO, rather than a se-
quence motif, is recognised and cleaved by SUMO prote-
ase which cleaves after two Gly residues at the C-terminus
of SUMO thus releasing the associated protein or peptide
with a native N-terminus. SUMO has been successfully
used for production of vesicle forming peptides [21] and
another self-assembling peptide EAK16 [22].
We have developed a SUMO-peptide expression strat-
egy suitable for producing soluble fusion proteins and
have recovered three different P11-family peptides, P11-4
and the complementary peptides P11-13 and P11-14 (K). In
the latter case the ornithine in the chemically prepared
peptide is replaced by lysine residues. We have charac-
terised these recombinant peptides and show that they be-
have essentially the same as previously characterised
chemically synthesised and recombinant peptides.
Results
Cloning and expression strategy
The pET SUMOadapt vector was kindly provided by
Bosse-Doenecke [23]. This modified vector carries an inser-
tion of a multiple cloning site with a BsaI site positionedconveniently to allow the cloning of a coding DNA se-
quence in-frame with the Gly-Gly motif at the C-terminal
cleavage site of SUMO protease [23]. However, the Invitro-
gen parent vector is based on pBR322 which has a low to
moderate copy number. As our objective was to enhance
the level of protein production we subcloned the SUMO
adapt region into a high copy number pET-28 vector. A
PCR reaction was performed using the primers
CpRd_NcoI_F and T7 reverse, and the product was cloned
into pET28c using restriction enzymes NcoI and BamHI.
This generated the expression vector pET28_SUMOadapt.
Peptide coding sequences, containing a translation termin-
ation codon to ensure a native C-terminal end, were cloned
into the BsaI site (Figure 1).
A S. cerevisiae SUMO protease gene codon-optimised
for E. coli expression was synthesised by Genscript and
was sub-cloned into the expression vector pET11a.
Expression of SUMO_P11-N and SUMO protease by
autoinduction
The term P11-N is used to represent any of the P11 fam-
ily of peptides. The pET28_SUMOadapt was tested for
SUMO protein production to select the optimal growth
medium and induction time. Auto-induction trials indi-
cated production of soluble protein using E. coli BL21
Star (DE3). Terrific broth (TB) and 8ZY media supple-
mented with 6% (v/v) 50 X 5052 [16] were tested and
TB with 5052 was found to result in a higher cell culture
density and level of SUMO production over the growth
period tested. The maximum OD600 was 45 correspond-
ing to a fusion protein level of 1.5 g/L. A harvest time of
64 hours was selected for maximal soluble protein
production.
Optimal yield of soluble SUMO protease was also
achieved under these conditions after 64 hours culture.
Extraction and purification of SUMO_P11-N and SUMO
Protease
Cells were lysed by cell disruption and centrifuged to re-
cover the soluble fraction. This was filtered and sub-
jected to immobilised metal affinity chromatography
(IMAC) purification by batch binding using nickel-
nitriloacetic acid (Ni-NTA) resin (Novagen) with batch
elution using 250 mM imidazole. A high level of purity
was achieved by this single purification step and the fu-
sion proteins were subjected to SUMO protease cleav-
age. A two hour incubation at 37°C in 1:1000 (SUMO
protease:SUMO fusion) mass ratio was sufficient to effi-
ciently cleave the fusion protein releasing the peptide.
Figure 2 shows SDS-PAGE results of a SUMO protease
cleavage experiment with the three SUMO fusion pro-
teins. The efficiency of cleavage was estimated to be
>90% by densitometry. Interestingly cleavage worked as
efficiently in water as in cleavage buffer (Figure 2). It is
Figure 1 Cloning strategy outlining the cloning of peptide coding regions at the BsaI restriction site of pET28_ SUMOadapt.
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SDS-PAGE migration characteristics of the SUMO-
peptide fusion proteins. SUMO-P11-4 and SUMO-P11-13
migrate in a similar manner and upon SUMO protease
cleavage the SUMO protein migrates further within theFigure 2 SDS-PAGE gels showing the cleavage of SUMO_P11-N with S
SUMO_P11-4 in either buffer (lanes 1 and 2) or water (lanes 3 and 4). B) SU
(lane 2) and C) SUMO_P11-14 (K) uncleaved (lane 1) and SUMO protease cl
Lanes 1 and 2 respectively to allow visualisation the released P11-14 (K) pepgel. By contrast the positively charged peptide causes the
SUMO-P11-14(K) to migrate more rapidly than the P11-4
or P11-13 fusion proteins. However, following SUMO
protease cleavage of P11-14(K) the SUMO shows an ap-
parent decrease in migration rate to a positionUMO protease. A) Uncleaved and SUMO protease cleaved
MO_P11-13 uncleaved (lane 1) and SUMO protease cleaved in water
eaved in water (lane 2). Lanes 3 and 4 show overloaded samples of
tide (lane 4). Lane 5 shows SUMO protease
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P11-4 and P11-13 fusion samples.Reverse phase HPLC (RP-HPLC)
Following peptide cleavage it was necessary to separate the
peptide from other reaction components by RP-HPLC. The
cleavage reaction mixture was adjusted to pH 9.0 with
NH4OH and incubated overnight before filtering (0.22 μm)
prior to injection onto a C18 column. The elution profile
was monitored at 220 and 280 nm and Figure 3 shows chro-
matograms of typical separations. The fractions were col-
lected using the 220 nm absorbance setting rather than 214
nm due to a limitation with the fraction collector. TheFigure 3 Average absorbance traces of cleaved SUMO_P11-N when pu
were made at 280 nm and 220 nm with the fraction collector programmed
identified to contain the peptide and SUMO protein are indicated by arrow
corresponding to P11-4 and the broader peak between 11 and 20 minutes
purificationfractions corresponding to distinct peaks were collected sep-
arately and analysed by mass spectrometry. The peptides
were in the major peaks eluting between 4 and 8 minutes
and were pooled and lyophilised. The difference in retention
time for P11-14 and associated SUMO compared with the
P11-4 and P11-13 samples is most likely due to the alterna-
tive buffer system used for this positively charged peptide.Mass spectrometry characterisation
To confirm the identity of the fusion proteins and peptides
electrospray mass spectrometry was performed. Fusion pro-
teins were dialysed overnight against 50 mM ammonium
bicarbonate (pH 8.0) using Spectra/POR 6 dialysis 1 kDarified using RP-HPLC on a C18 column. Absorbance measurements
to collect peaks at 220 nm. The positions of the peaks subsequently
s. A) P11-4 purification with the sharp peak at 6–7 minutes
corresponding to SUMO. B) P11-13 purification. C) P11-14 (K)
Table 1 Comparison of calculated and mass spectrometry
determined molecular masses of fusion protein and
peptide samples
Protein/peptide
sample
Calculated
mass (Da){
Observed
mass (Da)
Difference
(Da)
SUMO_P11-4 14821.4 14820.8 −0.6
SUMO_P11-13 14796.3 14796.4 +0.1
SUMO_P11-14 (K) 14790.5 14789.6 −0.9
SUMO cleaved 13284.8 13284.0 −0.8
P11-4 1554.6 1553.7 −0.9
P11-13 1529.5 1528.6 −0.9
P11-14 (K) 1523.8 1522.8 −1.0
{ The calculated molecular mass is of SUMO protein lacking the N-terminal
methionine residue.
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were lyophilised. The theoretical mass of the fusion proteins
were calculated by Expasy Protoparam for protein samples
lacking the N-terminal methionine and the masses mea-
sured by mass spectrometry are shown in Table 1. The
masses were in excellent agreement confirming the iden-
tities of the fusion proteins and the peptides.
Electrospray MS-MS sequencing confirmed the iden-
tity of nine of the eleven amino acids in each of the
peptides.Peptide quantification
UV spectroscopy was used to quantify the peptides
based on their theoretical extinction coefficients. SUMO
protein has 118 amino acids excluding the N-terminal
methionine, while the peptides comprise 11 amino acids,
representing between 10.3 and 10.7% of the mass of the
fusion proteins. In an experiment to compare the yields
of each peptide, a series of parallel purifications were
performed and the results are shown in Table 2. These
show that the peptides were well purified, with yields of
99.6% for P11-13, 84% for P11-4 and 46.1% for P
achieved. The reason for the lower yield for P11-14 may
be due to the different buffer system or the positively
charged nature of the peptide. The yield of 46% is good
but further work is required to determine the underlying
reason for the lower recovery and to try to optimise re-
covery of this peptide.Table 2 Yields of purified SUMO fusion proteins and peptides
Peptide Fusion protein
yield (mg/L)
Peptide as percentage
mass of fusion protein (%)
Theo
pept
P11-4 400 10.49 42.0
P11-13 500 10.34 51.7
P11-14 375 10.30 38.6Formation of peptide hydrogels
The purified peptides were dissolved in 140 mM NaCl to
a final concentration of 10 mg/mL. The pH of the P11-4
solution was adjusted to ca. 2.0 to trigger formation of a
self supporting gel. P11-13 and P11-14 were also prepared
to a final concentration of 10 mg/mL at ca. pH 7 and were
mixed in equal volumes to form a self supporting gel.
Figure 4A shows the hydrogel state for P11-13/P11-14
when combined.Characterisation of peptide fibril formation
Aggeli and colleagues reported the morphological struc-
ture of chemically synthesised P11-4 fibrils by transmis-
sion electron microscopy (TEM) [7,8]. Self supporting
gels for P11-4 and P11-13/P11-14 were diluted to 100 μM
in distilled water at pH 2.0 or 7.4 respectively. Fibril
morphologies were observed by TEM using uranyl acet-
ate negative staining. Figure 4B and C show the inter-
twining of fibrils creating fibres for P11-4 and P11-13/
P11-14(K) hydrogels, respectively. Both long and short
fibre structures were observed as isolated structures as
well as entangled masses. These are similar to structures
that have been previously observed with other samples
of these peptides [7,8,10,12].
The secondary structure of the peptide samples was
examined as a function of pH using circular dichroism.
Peptide hydrogels were diluted to 100 μM solutions.
Monomeric forms were also prepared as controls. The
results as shown in Figure 4D confirm the random coil
conformation of the monomeric forms of P11-4, P11-13
and P11-14(K), and the β-sheet conformations for the P11-
4 and P11-13/P11-14(K) hydrogels.
Discussion
Our previous work led to the development of E. coli ex-
pression systems capable of producing large amounts of
short self-assembling peptides of up to 370 mg/L culture
[10,12]. These were produced in the form of inclusion bod-
ies with recovery of the peptides from their fusion partner
by urea solubilisation and chemical cleavage. We were
interested to explore the extent to which we could express
the P11-family of β-structured peptides in a soluble format
through the use of soluble peptide fusions. We chose to
test the SUMO system as it enhances the solubility ofretical yield of
ide (mg/L)
Actual yield of peptide
purified (mg/L)
Percent theoretical
yield (%)
35.3 84.0
51.5 99.6
17.8 46.1
Figure 4 Hydrogel analysis of P11-13/P11-14. A) Hydrogel formed upon equimolar mixing of P11-13 and P11-14(K) indicated by arrow. B and C)
Transmission electron microscopy (TEM) images of self-assembled B) P11-4 at pH 2 and C) P11-13/P11-14(K). D) Circular dichroism analysis of P11-4,
P11-13 and P11-14(K) unimers, and P11-4 and P11-13/P11-14(K) hydrogels at pH 7.4. Random coil conformation is observed for peptide unimers
while a β-sheet conformation is observed for peptide hydrogels
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tion of difficult proteins with good yields and efficient puri-
fication [19,24-27]. Moreover, SUMO protease is highly
efficient and does not alter the target protein sequence
thereby producing native protein of high quality [28]. To
enhance the level of protein and peptide production we
required high levels of SUMO expression and therefore
subcloned the SUMO adapt region from pET SUMO
adapt [23] into a pET28c vector. Constructs were trans-
formed into E. coli strain BL21 (DE3) Star and TB-5052
media was used for expression of protein. SUMO-peptide
fusions were recovered at 0.37 to 0.5 g/L with HPLC purifi-
cation from the SUMO protease cleavage reaction resulting
in yields of soluble P11-peptides of between 18 and 35 mg/
L demonstrating that we have achieved good levels of re-
covery of purified peptides. It is likely this can be increased
significantly as the maximum yield of SUMO protein
achieved was 1.5 g/L compared to 637 mg/mL reported by
Li et al., [28] using a similar expression strategy, while for
EAK16 peptide production 250 mg/L of fusion protein was
reported by Satakarni et al., [22] by IPTG induction.
Cleavage of fusion protein by SUMO protease was
highly efficient in both cleavage buffer and in water. The
possibility of performing cleavage reactions in water fur-
ther demonstrates the efficiency of the system allowing
largely salt free solutions containing peptides to be
obtained thus reducing difficulties in downstream removalof salts prior to subsequent steps. It is interesting that the
SUMO protease works so efficiently in the presence of a
low concentration of reducing agent required for cysteine
protease function. The dithiothreitol (DTT) concentration
in the protease stock solution is 0.5 mM so upon dilution
by up to 10,000-fold in water for the cleavage reaction the
final concentration would be 50 nM.
We have previously characterised both chemically and
recombinantly produced P11- peptides [7,8,10-12]. In
this study TEM showed that rP11-4 formed fibrils with
lengths and widths similar to those reported for cP11-4
[7,8,10,12] and to our previously purified rP11-4 and
rP11-4(hsl) [10,12] and cP11-13/cP11-14 similar to those
previously observed [11]. Circular dichroism analysis
suggested that the predominant secondary structure of
rP11-4 and P11-13/P11-14 hydrogels at physiological pH
(pH 7.4) was antiparallel β-sheet as has been observed
previously [7,8,10-12]. Upon adjusting rP11-4 to pH 9, a
conformational transition to random coil occurred while
solutions of rP11-13 and rP11-14 alone also displayed
random coil conformation. We have previously demon-
strated that these P11- peptides are cytocompatible with
human primary fibroblasts [10,11].
Conclusions
We have demonstrated the use of a SUMO fusion
approach for efficient production and purification of
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native N- and C-termini. We have demonstrated that
SUMO protease displays efficient cleavage of the fusion
protein in water with a very low concentration of reducing
agent (50 nM) . The efficiency of SUMO protease cleavage
in water can be exploited to produce essentially salt and
ion-free solutions of various proteins/peptides for subse-
quent processing. The purified recombinant peptides be-
have similarly to chemically synthesized versions. Whilst
recombinant production has the potential to produce
large quantities of self-assembling peptides for tissue en-
gineering and industrial applications, the greatest benefits
are likely to derive from the soluble expression of such
peptides as fusions to a range of functional peptide and
protein domains to impart tailored biological functions
within self-assembled peptidic biomaterials.
Methods
Bacterial strains, plasmids and cell culture media
E. coli strain XL1 Blue (Stratagene, La Jolla, CA.) was
used for routine cloning while BL21 Star (DE3) Star
(Invitrogen, Carlsbad, CA) was used for expression. The
expression vectors, pET 28c+ and pET 11a+ (Novagen)
were used to express the SUMO fusion construct and
SUMO protease respectively. pET SUMOadapt was a
gift from Dr E. Bosse-Doenecke [23]. A codon optimised
SUMO protease gene was synthesised by Genscript and
delivered in a pUC 57 plasmid.
The growth media Luria Burtani broth (LB), 8ZY and
LB agar were prepared according to [29]. Terrific Broth
(TB) was purchased from HiMedia. Auto-induction
media were prepared according to the methods of Stu-
dier [16] and were supplemented by 6% (v/v) 50 X 5052
supplements. 5052 supplement corresponds to 0.5% (v/
v) glycerol, 0.05% (w/v) glucose and 2% (w/v) lactose.
Antibiotics carbenicillin and kanamycin were added to
media to final concentrations of 100 μg/mL and 50 μg/
mL respectively.
Generation of recombinant E. coli strains
Generation of pET28_SUMO fusion construct
The SUMO protein coding region was PCR amplified
from pET SUMOadapt [23] with an NcoI site at the 5’
end and a BamHI site at the 3’ end to allow cloning into
pET28c . A 50 μL PCR reaction containing 0.5 ng of
template DNA (pET SUMOadapt), 15 pmoles each of
CpRd_NcoI_F (GAGATATACCATGGGC) and T7 ter-
minator primer (TAGTTATTGCTCAGCGGTGG), 0.2
mM dNTPs, 1mM MgSO4, 1 X KOD buffer, 1 U KOD
Hot Start Polymerase (Novagen) was subjected to 1 mi-
nute at 95°C, 36 cycles of 30 seconds at 95°C, 30 seconds
at 55°C and 1 minute extension at 72°C followed by a
final extension for 10 minutes at 72°C. PCR products
were analysed on a 1.5% agarose gel and the correctproduct was purified using a QIAquick PCR clean up kit
(Qiagen cat. # 28104). This DNA fragment was digested
with NcoI and BamHI and purified as before. A 15 μL
reaction containing 1.2 μg of the pET28c vector was
digested with 20 units of NcoI and BamHI followed by
dephosphorylation with 10 units of Antarctic phosphat-
ase (NEB cat. #M0289L) and the vector backbone was
gel extracted (QIAquick Gel Extraction kit cat. #28704).
A 10 μL ligation reaction was set up containing 50 ng of
pET28c vector backbone, 100 ng of SUMO insert, 10
units of T4 DNA ligase and 1 X T4 DNA ligase buffer.Generation of rP11-N coding regions
Complementary oligonucleotides encoding self-assembling
peptides P11-4 (QQRFEWEFEQQ), P11-13 (EQEFEWE-
FEQE) and P11-14(K) (QQKFKWKFKQQ) were designed
to have a stop codon (bold) and 5’ TGGT or ACCA single
strand overhangs (underlined);
P11-4 F 5’-tggtcagcagcgctttgaatgggaatttgaacagcagtaa-3’
P11-4 R 5’-accattactgctgttcaaattcccattcaaagcgctgctg-3’
P11-13 F 5’-tggtgaacaggaatttgaatgggaatttgaacaggaataa-3’
P11-13 R 5’-accattattcctgttcaaattcccattcaaattcctgttc-3’
P11-14 (K) F 5’-tggtcagcagaaatttaaatggaaatttaaacagcagtaa-3’
P11-14 (K) R 5’-accattactgctgtttaaatttccatttaaatttctgctg-3’
The SUMOadapt region was designed by Bosse-
Doenecke [23] to exploit the BsaI restriction site for
cloning. In this case the ends created are ACCA allowing
peptide insertion immediately adjacent to the C-terminal
Gly-Gly motif (Figure 1).
Oligonucleotides were dissolved to a concentration
of 100 pmol/μl in distilled water. A 15 μL phosphoryl-
ation reaction was set up at 37°C for 30 min containing
600 pmol of oligonucleotide, 5 U of T4 polynucleotide
kinase (NEB cat. #M0236L) and 1 X T4 DNA ligase buf-
fer. The reaction mixture was heat inactivated at 65°C
for 20 minutes before 400 pmol of phosphorylated
forward and reverse oligonucleotides were mixed with
20 μl of 10 X annealing buffer (400mM Tris HCl pH
8.0, 100mM MgCl2 and 500 mM NaCl) in a final vol-
ume of 200 μl. The mixture was heated at 99°C for
10 minutes and allowed to cool down slowly to 50°C
to allow the complementary sequences to anneal.
Generation of fusion proteins
pET28_SUMOadapt was digested with BsaI and depho-
sphorylated using Antarctic phosphatase. Following a QIA-
quick clean-up, a ligation reaction containing 50 ng of this
DNA, 100 ng of peptide encoding DNA fragment, 1 μl of
10X ligase buffer (NEB) and 1 μl of T4 DNA ligase (NEB)
was incubated at room temperature for 4 hours. Following
transformation of XL1-Blue cells, colonies were screened
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T7 forward and reverse primers to identify recombinants
which were then sequenced to confirm their integrity.
Generation of SUMO protease expression construct
A His-SUMO protease [30] codon optimised DNA se-
quence was synthesised by Genscript in a pUC57 vector.
This was subcloned into pET 11a digested with NdeI and
BamHI and dephosphorylated. Colony PCR was used to
screen transformants and the coding region was verified
by DNA sequencing.
Fusion protein expression
Protein expression studies were performed using the auto-
induction protocol developed by Studier [16]. A single col-
ony was used to inoculate 2 mL of TB media containing
antibiotic with growth at 37°C for 6 hours at 250 rpm. A
250 μl aliquot of the culture was used to inoculate 400 mL
of TB-5052 auto-induction media in a 2L flask and incu-
bated at 25°C at 250 rpm. For time course experiments, 1
mL samples were collected at time intervals up to 64 h.
Cells were harvested at 64 h post inoculation by centrifu-
gation at 6000 rpm for 20 min using fixed angle rotor
(Sorvall SLA1500).
Preparation of soluble proteins from E. coli cultures
Cell pellets were re-suspended in extraction buffer (50
mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0)
supplemented with protease inhibitor cocktail (Complete
EDTA free protease inhibitors) (1 tablet/40 mL) and 20
Units of Omnicleave endonuclease. The cell suspension
was then subjected to two cycles of mechanical disruption
at 30,000 psi using a cell disruptor (Constant Cell Disrup-
tion Systems model 2 PLUS). Following cell lysis, the sol-
uble fraction was isolated by centrifugation at 13,000 x g
for 45 minutes to pellet the insoluble fraction. The super-
natant (soluble phase) was removed, filtered through a
0.22 μm filter (Sartorius) and stored at −80°C.
SUMO_peptide purification by immobilised IMAC
The Novagen ‘Batch Purification of 6X His-tagged pro-
teins from E. coli under native conditions’ protocol was
followed. The soluble fractions were filtered with a 0.45μm
filter (Sartorius) and loaded onto a pre-equilibrated Ni-
NTA column. Columns were then washed with extraction
buffer containing 50 mM then 100 mM imidazole and pro-
teins were eluted in elution buffer (50 mM NaH2PO4, 300
mM NaCl, 250 mM imidazole, pH 8.0). Proteins were con-
centrated using centrifugal filters (Amicon Ultra, Millipore)
and buffer exchanged in to either PBS or dH2O prior to
SUMO protease cleavage. This exchange was achieved by
repeated dilution and centrifugation with the required buf-
fer to remove trace salts.SDS-PAGE analysis
Protein samples were mixed in SDS loading buffer (12%
SDS, 6% mercaptoethanol, 30% Glycerol, 0.05% bromo-
phenol blue in 1M Tris–HCl (pH 6.8) in a 4:1 (v/v) ratio
of sample to loading buffer and heated at 95°C for 5
minutes. Samples were analysed using 4–12% NuPAGE
Novex Bis-tris precast gels (Invitrogen, UK) or home-
made 12% SDS-PAGE gels at 150 V for 1 hour. Protein
bands were visualized using Coomassie Blue G-250
(BDH Chemicals) or Simply BlueTM Safe stain (Invitro-
gen, UK).
Protein concentration determination
Protein concentrations were determined either by Brad-
ford assay (Bio-Rad cat. 500–0201) or UV spectroscopy.
Theoretical extinction coefficients were calculated using
ProtParam (http://ca.expasy.org/cgi-bin/protparam) to es-
timate the concentration according to Beer-Lambert Law.
The extinction coefficients for SUMO was 1490 M-1 cm-1,
P11-4 was 5500 M
-1 cm-1 while SUMO protease was
30035 M-1 cm-1.
SUMO protease expression, purification and storage
SUMO protease was expressed by autoinduction in E.
coli BL21 Star (DE3) and harvested after 64 hours. Cell
pellets were resuspended in binding buffer (50 mM
NaPi, 300 mM NaCl, 20 mM imidazole, pH 8.0) supple-
mented with Omnicleave endonuclease. SUMO protease
was purified by IMAC and immediately following elu-
tion, DTT was added to a concentration of 1 mM and
the purified SUMO protease was dialysed against phos-
phate buffered saline (PBS; 50 mM NaPi, 300 mM NaCl,
pH 8.0) with 1 mM DTT. This was concentrated and
quantified using a Bradford assay as 5 mg/mL. Finally
glycerol was added to 50% (v/v) and the SUMO protease
was stored at −80°C until required.
Cleavage of SUMO_peptide fusion protein with
recombinant SUMO protease
SUMO protease was used in a 1:1000 molar ratio for 2
hours or 1:10,000 molar ratio overnight for cleavage of
SUMO fusion protein. The reaction was carried out in
phosphate buffered saline (PBS) buffer (pH 8.0) in pres-
ence of 1mM DTT or in water without DTT and incu-
bated at 37°C. SDS-PAGE analysis was performed to
verify the cleavage.
Reversed phase high performance liquid chromatography
(RP HPLC)
A Dionex Summit machine using Chromeleon software
for peak analysis was used for reverse phase high per-
formance liquid chromatography (RP HPLC). A C 18
(Octadecyl derivatized silica) semiprep column was used
at room temperature to separate various peaks. P11-4
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nitrile/95% water, pH 9.0) and Buffer B (95% aceto-
nitrile/5% water, pH 9.0) which were adjusted to pH 9.0
using ammonium hydroxide (NH4OH) to maintain the
peptides’ unimeric conformation. Peptide P11-14 (K) was
purified with NH4OH, 0.1% and 0.06% trifluoroacetic
acid (TFA) added to Buffer A and Buffer B respectively.
All buffers were filtered through a 0.2 μm filter prior to
use. Samples were filtered using 0.45 μm filter prior to
loading. The semiprep column was initially equilibrated
with Buffer A at a flow rate of 2.0 mL/min and a blank
run was performed. Following sample injection at t = 0,
a gradient elution was performed from 0 – 90% Buffer B
over 20 minutes. The elution fractions were analysed
using absorbance measurement at 280 nm and 220 nm.
The fraction collector was programmed to collect peaks
from 220 nm absorbance. The process was repeated for
multiple injections to purify maximum amount of pep-
tide and peptide containing peaks were collected, pooled
and lyophilized before being submitted for mass spec-
trometry as a powder.
Mass spectrometry
Protein samples were dialysed against excess 50 mM
ammonium bicarbonate (pH 8.0) or dH2O overnight and
peptide samples were prepared by dissolving HPLC puri-
fied lyophilised powder in 20 μL of methanol containing
1 μL of 100% formic acid. Samples were submitted to
the Mass Spectrometry Facility, Astbury Centre, Univer-
sity of Leeds and analysed by Dr. James Ault on a Synapt
HDMS (Waters UK Ltd.) mass spectrometer. Peptide
samples were subsequently sequenced by tandem mass
spectrometry (MS-MS).
Formation of peptide hydrogels
Lyophilised peptide samples were dissolved in 140 mM
NaCl solution at pH 7.4 to a concentration of 10 mg/mL.
To unimerise the peptides, the pH was adjusted using 1
M NaOH and 1 M HCl (high pH for negative P11-4 and
P11-13 and low pH for P11-14 (K)). Self-assembly was
induced in P11-4 samples by reducing the pH below pH
7.0. For P11-13 and P11-14 (K) complementary-assembly
was achieved by mixing equimolar volumes.
Transmission electron microscopy
Self-assembled peptide gels of P11-4 and of P11-13/
P11-14 (K) were formed at 6.3 mM as described above.
Following overnight incubation at room temperature,
these were diluted with double distilled water to 100
μM. The morphology of the resulting fibrils was visua-
lized by TEM using uranyl acetate negative staining.
Glow-discharged, carbon coated 400 hexagonal mesh
copper grids were activated by UV light for 20 minutes.
Grids were covered with 20 μl of peptide solution andallowed to adsorb for 1 minute. Excess sample was
drained with filter paper and grids were negatively
stained using 10 μl of 4% uranyl acetate solution (w/v in
water) for 20 seconds. Excess solution was removed
using filter paper and grids were allowed to air dry be-
fore TEM analysis. Images were obtained using a Jeol
1200 EX TEM operating at 80 kV. Peptide hydrogels
were analysed in duplicate.Circular dichroism of recombinant peptides
Peptide gels were diluted to 100 μM in water as described
above. Samples were loaded in quartz cuvettes (Hellma)
with a path length of 1 mm. Mean residual ellipticity read-
ings were taken at far UV region of spectrum (190 nm to
260 nm) using a Jasco J-750 spectropolarimeter. Each
spectrum was the average of 8 scans with a step resolution
of 0.5 nm, scan speed 50 nm.min-1, response time of 1
second and a sensitivity of 50 m° at 20°C. Blank readings
were taken for all samples and subtracted from the pep-
tide samples results
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